The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

Ozempic and other weight loss jabs have recently gained a lot of fame, as people rush to buy and use them. However, many ...

The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

Experts warn the strange side effect could lead to delayed diagnoses and treatments, as well as unnecessary medical ...

A doctor has issued a warning over a worrying new side effect of drugs used to aid weight loss. Drugs such as Mounjaro, ...

A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested. Weight-loss drugs such as ...

Increased prostatic uptake of FDG is associated with a higher risk of Gleason 8 or higher disease. NIAGARA FALLS, Ont.—Fluorodeoxyglucose positron emission tomography (FDG-PET) findings can help ...

It has been suggested that an ‘unusual’ new side effect of weight-loss jabs is on the rise. While drugs like Ozempic and Mounjaro may have been used in Hollywood and A-list celebrity circles for a ...

While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer's disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, ...